Cardiac safety and potential efficacy: two reasons for considering minocycline in place of azithromycin in COVID-19 management.
作者信息
Diana Giovanni, Strollo Rocky, Diana Davide, Strollo Mirko, Galassi Alfredo R, Crea Filippo
机构信息
Department of Cardiovascular Science, Università Cattolica del Sacro Cuore, Rome, Italy.
Department of Medicine, Unit of Endocrinology & Diabetes, Università Campus Bio-Medico di Roma, Rome, Italy.
出版信息
Eur Heart J Cardiovasc Pharmacother. 2021 May 23;7(3):e53-e54. doi: 10.1093/ehjcvp/pvaa049.
Abstract
摘要
相似文献
1
Cardiac safety and potential efficacy: two reasons for considering minocycline in place of azithromycin in COVID-19 management.心脏安全性和潜在疗效：在新冠病毒疾病管理中考虑用米诺环素替代阿奇霉素的两个原因。
Eur Heart J Cardiovasc Pharmacother. 2021 May 23;7(3):e53-e54. doi: 10.1093/ehjcvp/pvaa049.
2
Azithromycin compared with minocycline in the treatment of acne comedonica and papulo-pustulosa.阿奇霉素与米诺环素治疗粉刺性痤疮和丘疹脓疱性痤疮的比较。
J Chemother. 1998 Dec;10(6):469-73. doi: 10.1179/joc.1998.10.6.469.
3
Comparison of minocycline and azithromycin for the treatment of mild scrub typhus in northern China.比较米诺环素和阿奇霉素治疗中国北方轻度恙虫病的疗效。
Int J Antimicrob Agents. 2016 Sep;48(3):317-20. doi: 10.1016/j.ijantimicag.2016.05.019. Epub 2016 Jul 12.
4
Therapeutic efficacy of macrolides, minocycline, and tosufloxacin against macrolide-resistant Mycoplasma pneumoniae pneumonia in pediatric patients.大环内酯类、米诺环素和托氟沙星治疗儿童耐大环内酯类肺炎支原体肺炎的疗效。
Antimicrob Agents Chemother. 2013 May;57(5):2252-8. doi: 10.1128/AAC.00048-13. Epub 2013 Mar 4.
5
Therapeutic efficacy of azithromycin, clarithromycin, minocycline and tosufloxacin against macrolide-resistant and macrolide-sensitive Mycoplasma pneumoniae pneumonia in pediatric patients.阿奇霉素、克拉霉素、米诺环素及妥舒沙星对小儿耐大环内酯类及大环内酯类敏感肺炎支原体肺炎的治疗效果
PLoS One. 2017 Mar 13;12(3):e0173635. doi: 10.1371/journal.pone.0173635. eCollection 2017.
6
Azithromycin as an alternative rosacea therapy when tetracyclines prove problematic.当四环素类药物出现问题时，阿奇霉素可作为酒渣鼻的替代疗法。
J Drugs Dermatol. 2008 Sep;7(9):898-9.
7
Azithromycin for Treatment of COVID-19.阿奇霉素用于治疗新型冠状病毒肺炎
Am Fam Physician. 2022 Mar 1;105(3):Online.
8
Doxycycline or minocycline may be a viable treatment option against SARS-CoV-2.强力霉素或米诺环素可能是对抗新型冠状病毒的一种可行治疗选择。
Med Hypotheses. 2020 Nov;144:110054. doi: 10.1016/j.mehy.2020.110054. Epub 2020 Jun 27.
9
Azithromycin, minocycline, moxifloxacin and spectinomycin failure in a case with persistent infection in Guangzhou, China.阿奇霉素、米诺环素、莫西沙星及大观霉素在中国广州一例持续性感染病例中治疗失败。
Int J STD AIDS. 2020 Oct;31(11):1106-1109. doi: 10.1177/0956462420905269. Epub 2020 Aug 25.
10
Clinical inquiries. Which oral antibiotics are best for acne?
J Fam Pract. 2011 May;60(5):290-2.
引用本文的文献
1
Comprehensive bioinformatics analysis and systems biology approaches to identify the interplay between COVID-19 and pericarditis.综合生物信息学分析和系统生物学方法鉴定 COVID-19 与心包炎之间的相互作用。
Front Immunol. 2024 Feb 22;15:1264856. doi: 10.3389/fimmu.2024.1264856. eCollection 2024.
2
Pharmacological basis for the potential role of Azithromycin and Doxycycline in management of COVID-19.阿奇霉素和多西环素在新冠病毒疾病管理中潜在作用的药理学基础。
Arab J Chem. 2021 Mar;14(3):102983. doi: 10.1016/j.arabjc.2020.102983. Epub 2021 Jan 10.
3
Pleiotropic Effects of Tetracyclines in the Management of COVID-19: Emerging Perspectives.四环素在新冠病毒疾病管理中的多效性作用：新观点
Front Pharmacol. 2021 Apr 23;12:642822. doi: 10.3389/fphar.2021.642822. eCollection 2021.
4
Concomitant use of dexamethasone and tetracyclines: a potential therapeutic option for the management of severe COVID-19 infection?地塞米松和四环素的联合使用：治疗严重 COVID-19 感染的潜在治疗选择？
Expert Rev Clin Pharmacol. 2021 Mar;14(3):315-322. doi: 10.1080/17512433.2021.1888714. Epub 2021 Mar 8.
5
The neuropsychiatric manifestations of COVID-19: Interactions with psychiatric illness and pharmacological treatment.COVID-19 的神经精神表现：与精神疾病的相互作用和药物治疗。
Biomed Pharmacother. 2021 Mar;135:111200. doi: 10.1016/j.biopha.2020.111200. Epub 2021 Jan 1.
本文引用的文献
1
An integrative drug repositioning framework discovered a potential therapeutic agent targeting COVID-19.一种综合药物重定位框架发现了一种针对 COVID-19 的潜在治疗药物。
Signal Transduct Target Ther. 2021 Apr 24;6(1):165. doi: 10.1038/s41392-021-00568-6.
2
No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection.对于重症新冠病毒感染患者，没有证据表明羟氯喹和阿奇霉素联合使用能实现快速的抗病毒清除或带来临床益处。
Med Mal Infect. 2020 Jun;50(4):384. doi: 10.1016/j.medmal.2020.03.006. Epub 2020 Mar 30.
3
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.羟氯喹和阿奇霉素治疗 COVID-19：一项开放标签非随机临床试验的结果。
Int J Antimicrob Agents. 2020 Jul;56(1):105949. doi: 10.1016/j.ijantimicag.2020.105949. Epub 2020 Mar 20.
4
In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).羟氯喹治疗严重急性呼吸综合征冠状病毒 2 （SARS-CoV-2）的体外抗病毒活性和优化剂量设计预测。
Clin Infect Dis. 2020 Jul 28;71(15):732-739. doi: 10.1093/cid/ciaa237.
5
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.《武汉 2019 年新型冠状病毒感染的肺炎 138 例住院患者临床特征分析》
JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585.
6
Risk Evaluation of Azithromycin-Induced QT Prolongation in Real-World Practice.阿奇霉素致 QT 间期延长的真实世界实践中的风险评估。
Biomed Res Int. 2018 Oct 14;2018:1574806. doi: 10.1155/2018/1574806. eCollection 2018.
7
Inhibition of microglial activation with minocycline at the intrathecal level attenuates sympathoexcitatory and proarrhythmogenic changes in rats with chronic temporal lobe epilepsy.在鞘内水平用米诺环素抑制小胶质细胞激活可减轻慢性颞叶癫痫大鼠的交感神经兴奋和促心律失常变化。
Neuroscience. 2017 May 14;350:23-38. doi: 10.1016/j.neuroscience.2017.03.012. Epub 2017 Mar 18.
8
Minocycline attenuates ischemia-induced ventricular arrhythmias in rats.米诺环素可减轻大鼠缺血诱导的室性心律失常。
Eur J Pharmacol. 2011 Mar 11;654(3):274-9. doi: 10.1016/j.ejphar.2011.01.001. Epub 2011 Jan 16.
9
Minocycline inhibits poly(ADP-ribose) polymerase-1 at nanomolar concentrations.米诺环素在纳摩尔浓度下可抑制聚（ADP - 核糖）聚合酶 -1。
Proc Natl Acad Sci U S A. 2006 Jun 20;103(25):9685-90. doi: 10.1073/pnas.0600554103. Epub 2006 Jun 12.
10
Phagolysosomal alkalinization and the bactericidal effect of antibiotics: the Coxiella burnetii paradigm.吞噬溶酶体碱化与抗生素的杀菌作用：伯氏考克斯体范例
J Infect Dis. 1992 Nov;166(5):1097-102. doi: 10.1093/infdis/166.5.1097.
Zotero 插件